Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3253 | 1952 | 36.0 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1398 | 7605 | COMMON VARIABLE IMMUNODEFICIENCY//PRIMARY IMMUNODEFICIENCY//IGA DEFICIENCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTRAVENOUS IMMUNOGLOBULIN | Author keyword | 87 | 25% | 16% | 303 |
2 | IVIG | Author keyword | 63 | 30% | 9% | 180 |
3 | INTRAVENOUS IMMUNOGLOBULINS | Author keyword | 36 | 29% | 5% | 102 |
4 | SUBCUTANEOUS IMMUNOGLOBULIN | Author keyword | 24 | 57% | 1% | 28 |
5 | IGIV | Author keyword | 23 | 70% | 1% | 19 |
6 | HIZENTRA | Author keyword | 20 | 100% | 0% | 9 |
7 | SUBCUTANEOUS IGG | Author keyword | 15 | 88% | 0% | 7 |
8 | SUBCUTANEOUS IMMUNOGLOBULIN THERAPY | Author keyword | 15 | 88% | 0% | 7 |
9 | PRIMARY IMMUNE DEFICIENCY DISEASES | Author keyword | 12 | 86% | 0% | 6 |
10 | INTRAVENOUS IGG | Author keyword | 9 | 64% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTRAVENOUS IMMUNOGLOBULIN | 87 | 25% | 16% | 303 | Search INTRAVENOUS+IMMUNOGLOBULIN | Search INTRAVENOUS+IMMUNOGLOBULIN |
2 | IVIG | 63 | 30% | 9% | 180 | Search IVIG | Search IVIG |
3 | INTRAVENOUS IMMUNOGLOBULINS | 36 | 29% | 5% | 102 | Search INTRAVENOUS+IMMUNOGLOBULINS | Search INTRAVENOUS+IMMUNOGLOBULINS |
4 | SUBCUTANEOUS IMMUNOGLOBULIN | 24 | 57% | 1% | 28 | Search SUBCUTANEOUS+IMMUNOGLOBULIN | Search SUBCUTANEOUS+IMMUNOGLOBULIN |
5 | IGIV | 23 | 70% | 1% | 19 | Search IGIV | Search IGIV |
6 | HIZENTRA | 20 | 100% | 0% | 9 | Search HIZENTRA | Search HIZENTRA |
7 | SUBCUTANEOUS IGG | 15 | 88% | 0% | 7 | Search SUBCUTANEOUS+IGG | Search SUBCUTANEOUS+IGG |
8 | SUBCUTANEOUS IMMUNOGLOBULIN THERAPY | 15 | 88% | 0% | 7 | Search SUBCUTANEOUS+IMMUNOGLOBULIN+THERAPY | Search SUBCUTANEOUS+IMMUNOGLOBULIN+THERAPY |
9 | PRIMARY IMMUNE DEFICIENCY DISEASES | 12 | 86% | 0% | 6 | Search PRIMARY+IMMUNE+DEFICIENCY+DISEASES | Search PRIMARY+IMMUNE+DEFICIENCY+DISEASES |
10 | INTRAVENOUS IGG | 9 | 64% | 0% | 9 | Search INTRAVENOUS+IGG | Search INTRAVENOUS+IGG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GAMMA GLOBULIN | 105 | 26% | 18% | 354 |
2 | IVIG | 62 | 37% | 7% | 133 |
3 | IGG SELF INFUSIONS | 58 | 86% | 2% | 30 |
4 | PRIMARY ANTIBODY DEFICIENCIES | 51 | 55% | 3% | 64 |
5 | POOLED HUMAN IGG | 50 | 77% | 2% | 34 |
6 | IMMUNE GLOBULIN | 46 | 15% | 15% | 285 |
7 | IMMUNE GLOBULIN THERAPY | 32 | 65% | 2% | 31 |
8 | IVIG THERAPY | 31 | 74% | 1% | 23 |
9 | PRIMARY HUMORAL IMMUNODEFICIENCY | 25 | 77% | 1% | 17 |
10 | SELF INFUSIONS | 21 | 73% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature | 2014 | 13 | 23 | 96% |
Intravenous immunoglobulin therapy: how does IgG modulate the immune system? | 2013 | 109 | 150 | 29% |
Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. | 2001 | 677 | 83 | 47% |
Intravenous immunoglobulin - Adverse effects and safe administration | 2005 | 110 | 37 | 86% |
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases | 2012 | 90 | 60 | 42% |
Intravenous immunoglobulin: Exploiting the potential of natural antibodies | 2012 | 40 | 34 | 56% |
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy | 2011 | 46 | 23 | 65% |
Venous and arterial thrombosis following administration of intravenous immunoglobulins | 2005 | 49 | 28 | 96% |
Adverse Effects of Human Immunoglobulin Therapy | 2013 | 16 | 80 | 78% |
Subcutaneous immunoglobulin replacement in primary immunodeficiencies | 2004 | 79 | 19 | 95% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EQUIPE IMMUNOPATHOL THER EUT IMMUNOINTERVENT 1 | 8 | 46% | 0.7% | 13 |
2 | HOSP ST GEORG GMBH LEIPZIG | 8 | 100% | 0.3% | 5 |
3 | CHAIR AUTOIMMUNE DIS | 5 | 63% | 0.3% | 5 |
4 | INT ASSOCIATED IMPACT | 5 | 41% | 0.5% | 9 |
5 | EQUIPE RECH CORDELIERS 16 | 3 | 100% | 0.2% | 3 |
6 | BIOCHEM MICROBIOL BIOINFORMAT | 3 | 24% | 0.5% | 10 |
7 | EQUIPE IMMUNOPATHOL IMMUNOINTERVENT THER EUT 1 | 2 | 67% | 0.1% | 2 |
8 | EQUIPE IMMUNOPATHOL THER EUT INTERVENT 16 | 2 | 67% | 0.1% | 2 |
9 | HEMA QUEBEC | 2 | 67% | 0.1% | 2 |
10 | SACKLER MED AUTOIMMUNE DIS | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000131727 | COMMON VARIABLE IMMUNODEFICIENCY//IGA DEFICIENCY//CVID |
2 | 0.0000118212 | NATURAL IGM ANTIBODIES//STEFAN ANGELOV MICROBIOL//ANTIBODY REPERTOIRES |
3 | 0.0000097408 | ELECTROLYTES IN BLOOD SERUM//GERIATRIC GYNECOLOGY//DESCENSUS |
4 | 0.0000096427 | IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//ITP |
5 | 0.0000082415 | MULTIFOCAL MOTOR NEUROPATHY//CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY//CIDP |
6 | 0.0000077029 | INFECTION DRUG THERAPY MORTALITY//CORD BLOOD NEUTROPHILS//FK 409 |
7 | 0.0000060128 | STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE |
8 | 0.0000058833 | TADEUSZ ORLOWSKI//MCGOOGAN LIB MED//ANTIBODY REPLACEMENT THERAPY |
9 | 0.0000055357 | IGG SUBCLASSES//MONOGRAPHS IN ALLERGY//IGG SUBCLASS |
10 | 0.0000048689 | ANTILIPID A//ELEBUTE SCORE//ANTIBIOTIC INDUCED ENDOTOXIN RELEASE |